Exercise‐induced pulmonary hypertension associated with systemic sclerosis: Four distinct entities

Publisher： John Wiley & Sons Inc

E-ISSN： 1529-0131|62|12|3741-3750

ISSN： 0004-3591

Source： Arthritis & Rheumatism, Vol.62, Iss.12, 2010-12, pp. : 3741-3750

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Bosentan: A Review of its Use in Pulmonary Arterial Hypertension and Systemic Sclerosis

By Oldfield Vicki   Lyseng-Williamson Katherine A.  

American Journal of Cardiovascular Drugs, Vol. 6, Iss. 3, 2006-01 ,pp. : 189-208

Adis International

Access to resources Recommend Favorite

Systemic Sclerosis-Related Pulmonary Hypertension: Unique Characteristics and Future Treatment Targets

By  

Current Pharmaceutical Design, Vol. 18, Iss. 11, 2012-04 ,pp. : 1457-1464

Bentham Science Publishers

Access to resources Recommend Favorite

Suppressive Effect of Sarpogrelate Hydrochloride on Respiratory Failure and Right Ventricular Failure with Pulmonary Hypertension in Patients with Systemic Sclerosis

By Kato S   Kishiro I   Machida M   Fuse D   Yoshida T   Kaneko N  

The Journal of International Medical Research, Vol. 28, Iss. 6, 2000-11 ,pp. : 258-268

Field House Publishing

Access to resources Recommend Favorite

Management of Pulmonary Arterial Hypertension Associated with Congenital Systemic-to-Pulmonary Shunts and Eisenmenger's Syndrome

By Galie Nazzareno  

Drugs, Vol. 68, Iss. 8, 2008-01 ,pp. : 1049-1066

Adis International

Access to resources Recommend Favorite

Exercise-Induced Asthma in Children

By Massie J.  

Pediatric Drugs, Vol. 4, Iss. 4, 2002-01 ,pp. : 267-278

Adis International

Access to resources Recommend Favorite